We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study.
- Authors
O'Day, S J; Maio, M; Chiarion-Sileni, V; Gajewski, T F; Pehamberger, H; Bondarenko, I N; Queirolo, P; Lundgren, L; Mikhailov, S; Roman, L; Verschraegen, C; Humphrey, R; Ibrahim, R; de Pril, V; Hoos, A; Wolchok, J D
- Abstract
This phase II study evaluated the safety and activity of ipilimumab, a fully human mAb that blocks cytotoxic T-lymphocyte antigen-4, in patients with advanced melanoma.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Vol 21, Issue 8, p1712
- ISSN
1569-8041
- Publication type
Journal Article
- DOI
10.1093/annonc/mdq013